Immune cells and bone: coupling goes both ways

References

• Alexander KA, Chang MK, Maylin ER, et al. (2011). Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res, 26, 1517–32
   PubMed Web of Science ®Google Scholar
• Bar-Shavit Z. (2007). The osteoclast: A multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell. J Cell Biochem, 102, 1130–9
   PubMed Web of Science ®Google Scholar
• Barbier V, Winkler IG, Levesque JP. (2012). Mobilization of hematopoietic stem cells by depleting bone marrow macrophages. Meth Mol Biol, 904, 117–38
   PubMedGoogle Scholar
• Bedi B, Li JY, Tawfeek H, et al. (2012). Silencing of parathyroid hormone (PTH) receptor 1 in T cells blunts the bone anabolic activity of PTH. Proc Natl Acad Sci USA, 109, E725–33
   Google Scholar
• Bluml S, McKeever K, Ettinger R, et al. (2013). B-cell targeted therapeutics in clinical development. Arthr Res Ther, 15, S4
   PubMed Web of Science ®Google Scholar
• Bowness P, Ridley A, Shaw J, et al. (2011). Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol, 186, 2672–80
   PubMed Web of Science ®Google Scholar
• Bromberg O, Frisch BJ, Weber JM, et al. (2012). Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood, 120, 303–13
   PubMed Web of Science ®Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, et al. (2003). Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841–6
   PubMed Web of Science ®Google Scholar
• Calvi LM, Bromberg O, Rhee Y, et al. (2012). Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells. Blood, 119, 2489–99
   PubMed Web of Science ®Google Scholar
• Champagne CM, Takebe J, Offenbacher S, Cooper LF. (2002). Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone, 30, 26–31
   PubMed Web of Science ®Google Scholar
• Chang MK, Raggatt LJ, Alexander KA, et al. (2008). Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol, 181, 1232–44
   PubMed Web of Science ®Google Scholar
• Choudhary S, Blackwell K, Voznesensky O, et al. (2013). Prostaglandin E acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Bone, 56, 31–41
   Google Scholar
• Colonna M. (2003). DAP12 signaling: From immune cells to bone modeling and brain myelination. J Clin Invest, 111, 313–14
   Web of Science ®Google Scholar
• Dalbeth N, Callan MF. (2002). A subset of natural killer cells is greatly expanded within inflamed joints. Arthritis Rheumat, 46, 1763–72
   PubMedGoogle Scholar
• Dalbeth N, Gundle R, Davies RJ, et al. (2004). CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol, 173, 6418–26
   PubMed Web of Science ®Google Scholar
• Despars G, Pandruvada SN, Anginot A, et al. (2013). DAP12 Overexpression induces osteopenia and impaired early hematopoiesis. PloS one, 8, e65297
   Google Scholar
• Ding L, Morrison SJ. (2013). Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature, 495, 231–5
   PubMed Web of Science ®Google Scholar
• Dougall WC, Glaccum M, Charrier K, et al. (1999). RANK is essential for osteoclast and lymph node development. Genes & Develop, 13, 2412–24
   PubMed Web of Science ®Google Scholar
• Duque G, Huang DC, Dion N, et al. (2011). Interferon-gamma plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. J Bone Miner Res, 26, 1472–83
   PubMed Web of Science ®Google Scholar
• Flanagan AM, Chambers TJ. (1992). Stimulation of bone nodule formation in vitro by prostaglandins E1 and E2. Endocrinology, 130, 443–8
   PubMed Web of Science ®Google Scholar
• Frisch BJ, Porter RL, Gigliotti BJ, et al. (2009). In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood, 114, 4054–63
   PubMed Web of Science ®Google Scholar
• Gao Y, Grassi F, Ryan MR, et al. (2007). IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest, 117, 122–32
   PubMed Web of Science ®Google Scholar
• Genetos DC, Yellowley CE, Loots GG. (2011). Prostaglandin E2 signals through PTGER2 to regulate sclerostin expression. PloS one, 6, e17772
   Google Scholar
• Gough AK, Lilley J, Eyre S, et al. (1994). Generalised bone loss in patients with early rheumatoid arthritis. Lancet, 344, 23–7
   PubMed Web of Science ®Google Scholar
• Greenbaum A, Hsu YM, Day RB, et al. (2013). CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance. Nature, 495, 227–30
   PubMed Web of Science ®Google Scholar
• Guihard P, Danger Y, Brounais B, et al. (2012). Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling. Stem Cells, 30, 762–72
   PubMed Web of Science ®Google Scholar
• Henriksen K, Karsdal MA, Martin TJ. (2013). Osteoclast-derived coupling factors in bone remodeling. Calcified Tissue Inter, May 23. [Epub ahead of print]
   Google Scholar
• Horowitz MC, Xi Y, Pflugh DL, et al. (2004). Pax5-deficient mice exhibit early onset osteopenia with increased osteoclast progenitors. J Immunol, 173, 6583–91
   PubMed Web of Science ®Google Scholar
• Horwood NJ, Elliott J, Martin TJ, Gillespie MT. (1998). Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology, 139, 4743–6
   PubMedGoogle Scholar
• Horwood NJ, Urbaniak AM, Danks L. (2012). Tec family kinases in inflammation and disease. Inter Rev Immunol, 31, 87–103
   PubMed Web of Science ®Google Scholar
• Horwood NJ, Kartsogiannis V, Quinn JM, et al. (1999). Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun, 265, 144–50
   PubMed Web of Science ®Google Scholar
• Howard GA, Bottemiller BL, Turner RT, et al. (1981). Parathyroid hormone stimulates bone formation and resorption in organ culture: Evidence for a coupling mechanism. Proc Natl Acad Sci USA, 78, 3204–8
   PubMed Web of Science ®Google Scholar
• Jandus C, Bioley G, Rivals JP, et al. (2008). Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum, 58, 2307–17
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Raisz LG, Voznesensky OS, et al. (1994). Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinology, 135, 1157–64
   PubMedGoogle Scholar
• Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. (1995). The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res, 1995, 36–46
   Google Scholar
• Kim YG, Lee CK, Nah SS, et al. (2007). Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun, 357, 1046–52
   Web of Science ®Google Scholar
• Kollet O, Dar A, Shivtiel S, et al. (2006). Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nature Med, 12, 657–64
   PubMed Web of Science ®Google Scholar
• Kong YY, Feige U, Sarosi I, et al. (1999a). Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 402, 304–9
   PubMed Web of Science ®Google Scholar
• Kong YY, Yoshida H, Sarosi I, et al. (1999b). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 397, 315–23
   PubMed Web of Science ®Google Scholar
• Kotake S, Udagawa N, Takahashi N, et al. (1999). IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest, 103, 1345–52
   PubMed Web of Science ®Google Scholar
• Levesque JP, Helwani FM, Winkler IG. (2003). Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Investig, 111, 187–96
   PubMed Web of Science ®Google Scholar
• Levesque JP, Helwani FM, Winkler IG. (2010). The endosteal ‘osteoblastic’ niche and its role in hematopoietic stem cell homing and mobilization. Leukemia, 24, 1979–92
   PubMed Web of Science ®Google Scholar
• Li L, Pettit AR, Gregory LS, Forwood MR. (2006). Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): A rose by any other name. Cytokine Growth Factor Rev, 17, 203–16
   Google Scholar
• Li Y, Li A, Yang X, Weitzmann MN. (2007a). B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood, 109, 3839–48
   PubMed Web of Science ®Google Scholar
• Li Y, Toraldo G, Li A, et al. (2007b). Ovariectomy-induced bone loss occurs independently of B cells. J Cell Biochem, 100, 1370–5
   Google Scholar
• Lo CK, Lam QL, Sun L, et al. (2008). Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum, 58, 2700–11
   PubMed Web of Science ®Google Scholar
• Loftus EV Jr, Achenbach SJ, Sandborn WJ, et al. (2003). Risk of fracture in ulcerative colitis: A population-based study from Olmsted County, Minnesota. Clin Gastroenterol Hepatol, 1, 465–73
   Google Scholar
• Lymperi S, Horwood N, Marley S, et al. (2008). Strontium can increase some osteoblasts without increasing hematopoietic stem cells. Blood, 111, 1173–81
   Google Scholar
• Lymperi S, Ersek A, Ferraro F, et al. (2011). Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood, 117, 1540–9
   Google Scholar
• Lymperi S, Ferraro F, Scadden DT. (2010). The HSC niche concept has turned 31. Has our knowledge matured? Ann NY Acad Sci, 1192, 12–18
   Google Scholar
• Madyastha PR, Yang S, Ries WL, KeyJr LL. (2000). IFN-gamma enhances osteoclast generation in cultures of peripheral blood from osteopetrotic patients and normalizes superoxide production. J Inter Soc Interferon Cytok Res, 20, 645–52
   Google Scholar
• Magrey M, Khan MA. (2010). Osteoporosis in ankylosing spondylitis. Curr Rheumatol Rep, 12, 332–6
   Google Scholar
• Mansour A, Abou-Ezzi G, Sitnicka E, et al. (2012). Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow. J Exper Med, 209, 537–49
   PubMedGoogle Scholar
• Mei HE, Schmidt S, Dorner T. (2012). Rationale of anti-CD19 immunotherapy: An option to target autoreactive plasma cells in autoimmunity. Arthritis Res Ther, 14, S1
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Yoshida S, Kawasumi M, et al. (2011). Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exper Med, 208, 2175–81
   Google Scholar
• Moore J, Ma D, Will R, et al. (2004). A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation. Bone Marrow Transplant, 34, 241–7
   PubMed Web of Science ®Google Scholar
• Nagata T, Kaho K, Nishikawa S, et al. (1994). Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int, 55, 451–7
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Takagi K, Kitaoka M, et al. (1993). Influence of monocyte-macrophage lineage cells on alkaline phosphatase activity of developing osteoblasts derived from rat bone marrow stromal cells. Nippon Seikeigeka Gakkai Zasshi, 67, 480–9
   Google Scholar
• Nakashima T, Takayanagi H. (2011). New regulation mechanisms of osteoclast differentiation. Ann NY Acad Sci, 1240, E13–18
   PubMed Web of Science ®Google Scholar
• Nam D, Mau E, Wang Y, et al. (2012). T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PloS one, 7, e40044
   PubMed Web of Science ®Google Scholar
• Nicolaidou V, Wong MM, Redpath AN, et al. (2012). Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One, 7, e39871
   PubMed Web of Science ®Google Scholar
• Nie H, Zheng Y, Li R, et al. (2013). Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med, 19, 322–8
   PubMed Web of Science ®Google Scholar
• Ninomiya T, Hosoya A, Hiraga T, et al. (2011). Prostaglandin E(2) receptor EP(4)-selective agonist (ONO-4819) increases bone formation by modulating mesenchymal cell differentiation. Eur J Pharmacol, 650, 396–402
   Google Scholar
• Nutt SL, Heavey B, Rolink AG, Busslinger M. (1999). Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature, 401, 556–62
   PubMed Web of Science ®Google Scholar
• Olson TS, Caselli A, Otsuru S, et al. (2013). Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning. Blood, 121, 5238--49
   Google Scholar
• Pollinger B, Junt T, Metzler B, et al. (2011). Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans. J Immunol, 186, 2602–12
   PubMed Web of Science ®Google Scholar
• Porter RL, Georger MA, Bromberg O, et al. (2013). Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury. Stem Cells, 31, 372–83
   PubMed Web of Science ®Google Scholar
• Quinn JM, Neale S, Fujikawa Y, et al. (1998). Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcified Tissue Inter, 62, 527–31
   PubMed Web of Science ®Google Scholar
• Quinn JM, Horwood NJ, Elliott J, et al. (2000). Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Amer Soc Bone Miner Res, 15, 1459–66
   PubMed Web of Science ®Google Scholar
• Raggatt LJ, Alexander KA, Kaur S, et al. (2013). Absence of B cells does not compromise intramembranous bone formation during healing in a tibial injury model. Amer J Pathol, 182, 1501–8
   Google Scholar
• Repovic P, Benveniste EN. (2002). Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci, 22, 5334–43
   Google Scholar
• Rifas L, Arackal S, Weitzmann MN. (2003). Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. J Cell Biochem, 88, 650–9
   Google Scholar
• Rifas L, Cheng SL, Shen V, Peck WA. (1989). Monokines produced by macrophages stimulate the growth of osteoblasts. Connect Tissue Res, 23, 163–78
   PubMed Web of Science ®Google Scholar
• Ruutu M, Thomas G, Steck R, et al. (2012). Beta-glucan triggers spondylarthritis and Crohn’s disease-like ileitis in SKG mice. Arthritis Rheum, 64, 2211–22
   PubMed Web of Science ®Google Scholar
• Sato K, Takayanagi H. (2006). Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol, 18, 419–26
   PubMed Web of Science ®Google Scholar
• Shinoda K, Sugiyama E, Taki H, et al. (2003). Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes. Bone, 33, 711–20
   Google Scholar
• Soderstrom K, Stein E, Colmenero P, et al. (2010). Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci USA, 107, 13028–33
   PubMedGoogle Scholar
• Spector TD, Hall GM, McCloskey EV, Kanis JA. (1993). Risk of vertebral fracture in women with rheumatoid arthritis. BMJ, 306, 558
   PubMed Web of Science ®Google Scholar
• Stier S, Ko Y, Forkert R, et al. (2005). Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exper Med, 201, 1781–91
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Kohara H, Noda M, Nagasawa T. (2006). Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 25, 977–88
   PubMed Web of Science ®Google Scholar
• Takayanagi, H. (2012). New developments in osteoimmunology. Nat Rev Rheumatol, 8, 684–9
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Ogasawara K, Hida S, et al. (2000). T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature, 408, 600–5
   PubMed Web of Science ®Google Scholar
• Tian XY, Zhang Q, Zhao R, et al. (2008). Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats. Bone, 42, 914–20
   PubMed Web of Science ®Google Scholar
• Toraldo G, Roggia C, Qian WP, et al. (2003). IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA, 100, 125–30
   PubMed Web of Science ®Google Scholar
• Tsukii K, Shima N, Mochizuki S, et al. (1998). Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun, 246, 337–41
   PubMed Web of Science ®Google Scholar
• Tyagi AM, Srivastava K, Mansoori MN, et al. (2012). Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: A new candidate in the pathogenesis of osteoporosis. PLoS One, 7, e44552
   PubMed Web of Science ®Google Scholar
• Walker EC, McGregor NE, Poulton IJ, et al. (2010). Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest, 120, 582–92
   PubMed Web of Science ®Google Scholar
• Weber JM, Forsythe SR, Christianson CA, et al. (2006). Parathyroid hormone stimulates expression of the Notch ligand Jagged1 in osteoblastic cells. Bone, 39, 485–93
   PubMedGoogle Scholar
• Weinreb M, Suponitzky I, Keila S. (1997). Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone, 20, 521–6
   PubMed Web of Science ®Google Scholar
• Weitzmann MN, Cenci S, Haug J, et al. (2000). B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem, 78, 318–24
   Google Scholar
• Winkler IG, et al. (2010). Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood, 116, 4815–28
   PubMed Web of Science ®Google Scholar
• Winkler IG, Sims NA, Pettit AR, et al. (2012). Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nature Med, 18, 1651–7
   PubMed Web of Science ®Google Scholar
• Xie C, Ming X, Wang Q, et al. (2008). COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone, 43, 1075–83
   Google Scholar
• Yun TJ, Tallquist MD, Aicher A, et al. (2001). Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function. J Immunol, 166, 1482–91
   PubMed Web of Science ®Google Scholar
• Zaiss MM, Frey B, Hess A, et al. (2010). Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol, 184, 7238–46
   PubMed Web of Science ®Google Scholar
• Zarling JM, Shoyab M, Marquardt H, et al. (1986). Oncostatin M: A growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA, 83, 9739–43
   PubMed Web of Science ®Google Scholar
• Zhang J, Niu C, Ye L, et al. (2003). Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425, 836–41
   PubMed Web of Science ®Google Scholar